Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Immunol ; 163(8): 4253-61, 1999 Oct 15.
Article in English | MEDLINE | ID: mdl-10510363

ABSTRACT

We previously showed that LFA-1-dependent in vitro invasion and in vivo migration of a T cell hybridoma was blocked in cells overexpressing a truncated dominant-negative zeta-associated protein (ZAP)-70. The truncated ZAP-70 also blocked LFA-1-dependent chemotaxis through ICAM-1-coated filters induced by 1 ng/ml stromal cell-derived factor-1, but not LFA-1-independent chemotaxis induced by 100 ng/ml stromal cell-derived factor-1. This suggested that LFA-1 engagement triggers a signal that amplifies a weak chemokine signal and that dominant-negative ZAP-70 blocks this LFA-1 signal. Here we show that cross-linking of part of the LFA-1 molecules with Abs causes activation of free LFA-1 molecules (not occupied by the Ab) on the same cell, which then bind to ICAM-2 on other cells. This causes cell aggregation that was also blocked by dominant-negative ZAP-70. Thus, an LFA-1 signal involving ZAP-70 activates other LFA-1 molecules, suggesting that the chemokine signal can be amplified by multiple cycles of LFA-1 activation. The chemokine and the LFA-1 signal were both blocked by a phospholipase C inhibitor and a calpain inhibitor, suggesting that one of the amplified signals is the phospholipase C-dependent activation of calpain. Finally, we show that both Src-homology 2 domains are required for inhibition of invasion, chemotaxis, and aggregation by the truncated ZAP-70, suggesting that ZAP-70 interacts with a phosphorylated immunoreceptor tyrosine-based activation motif (ITAM) sequence. Remarkably, this is not an ITAM in the TCR/CD3 complex because this is not expressed by this T cell hybridoma.


Subject(s)
Cell Movement/immunology , Hybridomas/immunology , Lymphocyte Function-Associated Antigen-1/physiology , Protein-Tyrosine Kinases/physiology , Signal Transduction/immunology , T-Lymphocytes/enzymology , T-Lymphocytes/immunology , Animals , Antibodies, Monoclonal/metabolism , Antibodies, Monoclonal/pharmacology , Antigens, CD/physiology , Binding Sites, Antibody , Calpain/antagonists & inhibitors , Calpain/physiology , Cell Adhesion/immunology , Cell Adhesion Molecules/physiology , Cell Aggregation/drug effects , Cell Aggregation/immunology , Cell Movement/drug effects , Dose-Response Relationship, Immunologic , Enzyme Inhibitors/pharmacology , Hybridomas/drug effects , Hybridomas/enzymology , Hybridomas/metabolism , Immunoglobulin Fab Fragments/metabolism , Isoenzymes/antagonists & inhibitors , Isoenzymes/physiology , Lymphocyte Function-Associated Antigen-1/immunology , Lymphocyte Function-Associated Antigen-1/metabolism , Mice , Peptide Fragments/immunology , Peptide Fragments/metabolism , Phospholipase C gamma , Protein-Tyrosine Kinases/biosynthesis , Rats , Stilbenes/pharmacology , T-Lymphocytes/drug effects , T-Lymphocytes/metabolism , Type C Phospholipases/antagonists & inhibitors , Type C Phospholipases/physiology , ZAP-70 Protein-Tyrosine Kinase
2.
Exp Cell Res ; 231(2): 242-50, 1997 Mar 15.
Article in English | MEDLINE | ID: mdl-9087164

ABSTRACT

T-cell hybridomas metastasize widely, and the extent of dissemination correlates with invasiveness in fibroblast cultures. Previously, we provided evidence that both metastasis and in vitro invasion require activation of LFA-1, induced by G-protein-transduced signals triggered by as yet unidentified factors. We show here that LFA-1-mediated adhesion of TAM2D2 T-cell hybridoma cells to ICAM-1 can in fact be induced by direct activation of G-proteins using AIF-4, to the same extent as by using PMA or Mn2+. We assessed effects of protein kinase C (PKC), tyrosine kinase (TK), PI3-kinase (PI3K), and phospholipase C (PLC) inhibitors. Both AIF-4-induced adhesion and invasion were completely blocked by the TK inhibitor genistein and partially blocked by the PI3K inhibitor wortmannin, but not influenced by PKC inhibitor GF109203X. Downregulation of PKC did not affect invasion or adhesion induced by AIF-4 either. In contrast, GF109203X and PKC downregulation blocked PMA-induced adhesion, but genistein and wortmannin had no effect. Invasion and both AIF-4- and PMA-induced adhesion were completely blocked by the PLC inhibitor U73122. Mn(2+)-induced adhesion, which was not or was only partially blocked by the other inhibitors, was delayed by U73122, and spreading of Mn(2+)-treated cells was completely prevented by U73122. However, PLC activity during adhesion was not detected. We conclude that signals required for invasion and G-protein-induced adhesion are similar and are distinct from PKC-induced adhesion, and that in all cases PLC is likely to be activated, but is probably too local and/or transient to be detected.


Subject(s)
Aluminum Compounds/pharmacology , Fluorides/pharmacology , GTP-Binding Proteins/metabolism , Hybridomas/drug effects , Intercellular Adhesion Molecule-1/metabolism , Lymphocyte Function-Associated Antigen-1/metabolism , Manganese/pharmacology , Neoplasm Proteins/physiology , Phosphoric Diester Hydrolases/physiology , Protein Kinase C/physiology , Protein-Tyrosine Kinases/physiology , Signal Transduction/drug effects , T-Lymphocytes/drug effects , Tetradecanoylphorbol Acetate/pharmacology , Androstadienes/pharmacology , Animals , Cell Adhesion/drug effects , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Estrenes/pharmacology , Genistein , Humans , Hybridomas/metabolism , Indoles/pharmacology , Isoflavones/pharmacology , Maleimides/pharmacology , Mice , Neoplasm Invasiveness , Neoplasm Proteins/antagonists & inhibitors , Phosphatidylinositol 3-Kinases , Phosphatidylinositol 4,5-Diphosphate/metabolism , Phosphatidylinositol Diacylglycerol-Lyase , Phosphodiesterase Inhibitors/pharmacology , Phosphoric Diester Hydrolases/drug effects , Phosphotransferases (Alcohol Group Acceptor)/antagonists & inhibitors , Protein Kinase C/antagonists & inhibitors , Protein-Tyrosine Kinases/antagonists & inhibitors , Pyrrolidinones/pharmacology , T-Lymphocytes/metabolism , Wortmannin
SELECTION OF CITATIONS
SEARCH DETAIL
...